COVID-19: Corbevax Gets DCGI Nod for Use in Kids, Delhi Logs 360 New Cases

Catch all the latest updates on the coronavirus pandemic here.
The Quint
India
Updated:

Centre asks states and UTs to review and amend the additional COVID-19 restrictions that were imposed after a sudden surge in infections.

|

(Photo: Aroop Mishra/The Quint)

<div class="paragraphs"><p>Centre asks states and UTs to review and amend the additional <a href="https://www.thequint.com/coronavirus/covid-19-coronavirus-omicron-live-updates">COVID-19 restrictions </a>that were imposed after a sudden surge in infections.</p></div>
ADVERTISEMENT

Tracing a downward trend, India recorded 16,051 new coronavirus cases and 203 deaths due to the viral disease on Monday, 21 February.

India's positivity rate stands at 1.93 percent, and the number of active cases has declined to 2,02,131.

Meanwhile, Biological E Ltd said in a statement on Monday that its Corbevax vaccine, India's first indigenously-developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19, has received emergency use authorisation (EUA) from India's drug regulator DGCI for age group 12-18 years.

  • Mumbai reported 167 daily cases on Sunday, while Delhi saw 570 infections

  • Over 80 percent of India's adult population is now vaccinated against COVID-19, Health Minister Mansukh Mandaviya said on Saturday

  • Queen Elizabeth tested positive for COVID-19, Buckingham Palace announced on Sunday

(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)

Mizoram Reports 519 New Cases

Mizoram detects 519 fresh infections in the last 24 hours, taking the active caseload in the state to 9,919.

J&K: Offline Classes Begin for Classes 1-8

Physical classes for classes 1 to 8 resumed in Summer Zone schools of Jammu and Kashmir today.

Jharkhand Records 69 New COVID Cases, No Deaths

Jharkhand recorded 69 fresh COVID cases on Monday, 21 February. The tally rose to 4,33,999 cases with the new infections, a health bulletin said.

The coronavirus death toll remained unchanged at 5,315 as no fresh fatality was recorded.

Ranchi district recorded the highest number of new cases at 16, while 12 infections were registered in East Singhbhum district.

The state now has 690 active cases, while 4,27,994 people have recovered from the disease so far.

Schools Reopen in Goa; Shiv Sena Opposes Signed Consent Forms  

Schools began in offline mode across the state on Monday, 21 February, after a break due to the COVID-19 pandemic, and the management of several institutions asked parents to fill consent forms which made it clear that students were attending class at their own risk.

However, the Shiv Sena on Monday opposed the signing of consent forms from parents saying that "It is the schools’ responsibility to take care of students within the campus."

Domestic Air Traffic To Cross Pre-COVID Levels in 2 Months: Scindia

The number of daily air passengers is expected to cross pre-COVID levels in the next two months, said Jyotiraditya Scindia, Civil Aviation Minister, on Monday, 21 February, as reported by news agency PTI.

He also urged states to reduce tax on jet fuel to boost the country's aviation sector.

Odisha Logs 388 New COVID-19 Cases, 15 Deaths

Odisha’s COVID-19 tally rose to 12,82,869 on Monday, 21 February, as 388 more people tested positive for the infection, a health bulletin said. A total of 86 children were among the new patients.

Odisha recorded 15 fresh fatalities which pushed the state’s coronavirus death toll to 9,026, it said. The daily positivity rate was 0.72 percent as 53,690 samples were tested in the last 24 hours.

Severe COVID-19 Disrupts Gut Health: Study

Severe COVID-19 compromises the gut health, according to a study published in the journal Frontiers in Immunology.

The research looked at samples of gastrointestinal tract from patients who died after being diagnosed with COVID-19 during the first wave of the pandemic, as reported by PTI.

ADVERTISEMENT
ADVERTISEMENT

DCGI Grants Emergency Use Approval to Corbevax for Kids Aged 12-18

Biological E Ltd said in a statement on Monday that its Corbevax vaccine, India's first indigenously-developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19, has received emergency use authorisation (EUA) from India's drug regulator DGCI for age group 12-18 years.

Kerala Reports 4069 Fresh COVID-19 Cases

Kerala reported 4069 fresh COVID-19 cases, 11,026 recoveries and 11 deaths in the last 24 hours.

The state government said that a total of 76 deaths which were not added due to lack of documents and 41 deaths as per new guidelines of central government have been added.

The current death toll stands at 64,273, with active cases being at 58,932.

Mumbai Reports Less Than 100 COVID Cases

Mumbai reported 96 fresh cases and 1 death in the last 24 hours. The city has reported less than 100 cases for the first time after 17 April 2020. Active cases stand at 1415.

Karnataka Logs 679 New Cases

Karnataka reported 679 new cases and 21 deaths on Monday. Active case tally is at 11,360.

Himachal Pradesh Logs 144 New COVID-19 Cases

Himachal Pradesh on Monday reported 144 new cases and 1 death due to coronavirus.

Assam Reports 28 New COVID-19 Cases

Assam reported 28 fresh COVID-19 cases and 2 deaths on Monday.

Delhi Logs 360 New COVID-19 Cases, 4 Deaths

Delhi reported 360 new cases and 4 deaths due to COVID-19 on Monday.

Health Minister Mandaviya Hails DCGI Approval of Corbevax

"The CDSCO has granted emergency use authorisation to COVID-19 vaccine CORBEVAX for 12-18 year age group. It is India's 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against COVID-19. This will further strengthen our fight against COVID-19," tweeted Health Minister Mansukh Mandaviya.

Published: 21 Feb 2022,10:04 AM IST

ADVERTISEMENT
SCROLL FOR NEXT